Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:YALA
NYSE:YALAInteractive Media and Services

Assessing Yalla Group (YALA) Valuation After New US$150 Million Buyback And Q1 2026 Revenue Guidance

Why Yalla Group (YALA) is back on investors’ radar Yalla Group (YALA) has drawn fresh attention after its board approved a new share repurchase program of up to US$150 million, alongside first quarter 2026 revenue guidance that factors in the timing of Ramadan. See our latest analysis for Yalla Group. Those moves come after a period where the 1 year total shareholder return of 76.9% contrasts with a more muted 0.7% year to date share price return at US$7.11, suggesting recent momentum has...
NYSE:MTD
NYSE:MTDLife Sciences

Why Mettler-Toledo (MTD) Is Down 5.8% After Tariff-Driven Margin Squeeze And Cautious 2025 Outlook

In Q2 2025, Mettler-Toledo International reported marginal revenue growth but weaker gross and operating margins as higher tariffs and macroeconomic pressures weighed on profitability, and management issued cautious full-year 2025 guidance. Even as near-term earnings face pressure, the company is emphasizing bioprocessing and manufacturing onshoring as areas it believes could reshape its longer-term business mix. We’ll now examine how the tariff-driven margin squeeze highlighted in the...
TSX:SJ
TSX:SJForestry

Stronger 2025 Earnings And Higher Dividend Could Be A Game Changer For Stella-Jones (TSX:SJ)

Stella-Jones Inc. recently reported fourth quarter 2025 sales of CA$727 million and net income of CA$50 million, alongside full-year 2025 sales of CA$3.49 billion and net income of CA$337 million, and the Board declared a quarterly dividend of CA$0.34 per share payable on April 24, 2026. The combination of modest quarterly earnings softness, improved full-year profitability and a higher dividend suggests management’s confidence in the company’s cash generation and longer-term outlook. We’ll...
NasdaqCM:EXAS
NasdaqCM:EXASBiotechs

Exact Sciences EHR Outreach Lifts CRC Screening And Fuels Investor Interest

Exact Sciences, Amalgam Rx and Privia Health report materially higher colorectal cancer screening rates using EHR-enabled outreach and at home noninvasive tests. The coordinated program is described as scalable and has surpassed national screening benchmarks during Colorectal Cancer Awareness Month. The initiative focuses on closing screening gaps by embedding screening prompts and workflows directly into clinical systems and patient communications. For investors watching NasdaqCM:EXAS,...
TSX:DSV
TSX:DSVMetals and Mining

What Does a Director’s Big Share Buy Reveal About Discovery Silver’s (TSX:DSV) Board-Shareholder Alignment?

Earlier this month, Discovery Silver director William Murray John acquired 140,000 common shares on a direct basis, more than doubling his personal stake in the company. This sizeable insider purchase highlights growing alignment between board oversight and shareholder interests, as a key decision‑maker increases direct exposure to Discovery Silver’s performance. We’ll now explore how this substantial insider buying might influence Discovery Silver’s existing investment narrative and the way...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

A Look At Nurix Therapeutics (NRIX) Valuation After Expanded Equity Distribution Agreement

Why Nurix Therapeutics (NRIX) moved after its latest capital move Nurix Therapeutics (NRIX) recently expanded its equity distribution agreement, giving it room to sell up to $413.65 million of common stock through Piper Sandler. This step directly affects its capital-raising flexibility and potential dilution. See our latest analysis for Nurix Therapeutics. The capital plan arrives after a tougher few months for the share price, with a 30 day share price return showing an 8% decline and a 90...
BME:ROVI
BME:ROVIPharmaceuticals

Assessing Laboratorios Farmaceuticos Rovi (BME:ROVI) Valuation After 2025 Results Dividend Hike And 2026 Guidance

Earnings, dividend proposal and guidance at a glance Laboratorios Farmaceuticos Rovi (BME:ROVI) has drawn fresh attention after releasing its 2025 results, proposing a higher cash dividend and reaffirming its 2026 operating revenue guidance. This provides investors with updated information on profitability and capital returns. See our latest analysis for Laboratorios Farmaceuticos Rovi. The earnings release and dividend proposal come after a strong run in the shares, with a 30 day share price...
NYSE:VTOL
NYSE:VTOLEnergy Services

Will Solid Q4 Results, Dividend, And 2026 Guidance Change Bristow Group's (VTOL) Narrative

On February 25, 2026, Bristow Group Inc. reported fourth-quarter 2025 sales of US$377.26 million and net income of US$18.42 million, alongside a US$0.125 quarterly dividend and affirmed 2026 revenue guidance of US$1.58 billion to US$1.69 billion. The combination of stronger full-year 2025 profitability, reiterated revenue expectations for 2026, and continued cash returns via dividends underscores management’s confidence in Bristow’s operating outlook. With 2026 revenue guidance now on the...
ASX:STO
ASX:STOOil and Gas

Could Santos (ASX:STO) Asset Demerger Plans Reframe Its LNG-Focused Portfolio for Strategic Suitors?

Santos Limited (ASX:STO) has reportedly been weighing a demerger of its lower-performing Western Australia, Cooper Basin, Narrabri and Dorado assets as part of an Australian business strategic review that sources say could involve either an in‑specie distribution or an outright sale to a buyer such as Beach Energy. This potential separation of non-core assets, and the associated remediation liabilities, could reshape Santos into a more focused LNG and Alaska portfolio that may be more...
NasdaqGS:PLXS
NasdaqGS:PLXSElectronic

Assessing Plexus (PLXS) Valuation After A Strong 1 Year Share Price Rally

Recent share performance and what it means for Plexus (PLXS) investors Plexus (PLXS) has caught investor attention after a strong past 3 months, with a total return above 20% and a 1 year return above 50%, despite a weaker month. That mix of shorter term softness and stronger longer term gains raises a practical question for you as an investor: whether the current share price around $191.58 still lines up with the company’s fundamentals. See our latest analysis for Plexus. Recent trading has...
XTRA:AG1
XTRA:AG1Specialty Retail

A Look At AUTO1 Group’s (XTRA:AG1) Valuation After Updated 2026 Production Guidance

Updated production outlook and what it could mean for investors AUTO1 Group (XTRA:AG1) has issued new production guidance for 2026, projecting total units between 940,000 and 1,000,000, with both Merchant and Retail segments expected to be above their 2025 unit levels. For investors, this updated outlook places upcoming volume execution in focus, as the company targets 815,000 to 865,000 units in Merchant and 125,000 to 135,000 units in Retail for the year. See our latest analysis for AUTO1...
ASX:DDR
ASX:DDRElectronic

A Look At Dicker Data’s Valuation After FY25 Results And Fully Franked Dividend Announcement

Dicker Data (ASX:DDR) has drawn fresh attention after releasing its full year 2025 results, reporting higher sales, revenue and net income, and declaring a fully franked final quarterly dividend of A$0.115 per share. See our latest analysis for Dicker Data. Despite the full year 2025 results and higher fully franked dividend drawing focus, Dicker Data’s 1 day share price return of 3.6% comes after weaker recent momentum. The 90 day share price return of 13.82% and 1 year total shareholder...
XTRA:ENR
XTRA:ENRElectrical

Is It Time To Rethink Siemens Energy (XTRA:ENR) After A 195% One Year Surge?

If you are wondering whether Siemens Energy's share price reflects its underlying value or has moved ahead of itself, you are not alone. This article will walk through what the current market price might be implying. The stock has seen a mixed pattern recently, with an 8.4% decline over the last 7 days and a 2.1% decline over the last 30 days, set against a 21.1% gain year to date and a very large 1 year return of 195.5% that has lifted it several times higher over 3 years. Recent headlines...
TSXV:SLVR
TSXV:SLVRMetals and Mining

Is Silver Tiger Metals (TSXV:SLVR) Trading Higher Losses for a Clearer Project Strategy?

Silver Tiger Metals Inc. recently reported results for the third quarter and nine months ended December 31, 2025, posting a third-quarter net loss of C$1.93 million versus C$1.35 million a year earlier and a nine‑month net loss of C$3.66 million versus C$3.11 million. Although the basic loss per share from continuing operations held steady at C$0.01, the widening net loss may prompt investors to reassess how the company is managing its expenses and project pipeline. We will now look at how...
NYSE:ACCO
NYSE:ACCOCommercial Services

ACCO Brands (ACCO) Return To Profit Tests Bearish Earnings Narrative

ACCO Brands (ACCO) has reported its FY 2025 third quarter with revenue of US$383.7 million and EPS of US$0.04, alongside net income of US$4 million. The trailing 12 month figures show revenue of US$1.54 billion and EPS of US$0.44 supported by net income of US$40.6 million. Over recent quarters the company has seen revenue move from US$438.3 million with EPS of a US$1.29 loss and a net loss of US$125.2 million in Q2 2024 to US$394.8 million with EPS of US$0.32 and net income of US$29.2 million...
NasdaqGS:NUVL
NasdaqGS:NUVLBiotechs

Assessing Nuvalent (NUVL) Valuation After Wider Losses And A New Shelf Registration

Why Nuvalent’s latest results are in focus Nuvalent (NUVL) is back on investors’ radar after reporting a fourth quarter net loss of US$118.71 million and a full-year net loss of US$425.38 million, along with a new US$458.37 million shelf registration filing. See our latest analysis for Nuvalent. At a share price of US$102.32, Nuvalent has seen a 1-day share price return of 2.93% and a year-to-date share price return of 1.47%. Its 1-year total shareholder return of 51.86% and very large 3-year...
NasdaqGS:TRMB
NasdaqGS:TRMBSoftware

Trimble’s Paris Grand Role And Insider Selling Shape Valuation Picture

Trimble is supplying technology for the Paris Grand construction project, keeping the company tied to one of Europe’s highest profile infrastructure builds. At the same time, company insiders have been consistently selling shares of NasdaqGS:TRMB over the past year, with no insider purchases reported. These two threads, project execution in France and insider activity at home, give investors fresh information on Trimble beyond recent earnings headlines. Trimble, trading at $70.45, sits at...
SWX:COPN
SWX:COPNPharmaceuticals

Cosmo Pharmaceuticals (SWX:COPN) Swings To Loss And Tests Bullish Profitability Narratives

Cosmo Pharmaceuticals (SWX:COPN) has kicked off FY 2025 with first half revenue of €51.7 million and a basic EPS loss of €0.13, following FY 2024 second half revenue of €130.6 million with basic EPS of €3.45 and first half 2024 revenue of €136.2 million with basic EPS of €4.42. Over the trailing twelve months in the data, revenue is €182.3 million with basic EPS of €3.68. Investors may focus on how the latest dip into a small loss fits against a period where margins and earnings have...
NYSE:AMPX
NYSE:AMPXElectrical

Amprius Revenue Record And SiCore Wins Tested Against Rich Valuation

Amprius Technologies (NYSE:AMPX) reported record fourth quarter revenue. The company highlighted broad adoption of its second generation SiCore silicon anode batteries. Nokia Drone Networks selected Amprius SiCore batteries, adding a high profile commercial reference. Amprius said it is ahead of schedule on NDAA compliance, improving eligibility for future U.S. government contracts. Amprius focuses on high performance silicon anode batteries aimed at applications where weight, power, and...
NYSE:PNFP
NYSE:PNFPBanks

Is Pinnacle Financial Partners (PNFP) Pricing Reflect Recent Regional Bank Concerns Accurately?

If you are wondering whether Pinnacle Financial Partners is offering fair value at its current share price, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at US$87.29, with returns of a 5.8% decline over 7 days, a 14.6% decline over 30 days, an 8.2% decline year to date, an 11.1% decline over 1 year, 58.6% over 3 years, and 1.1% over 5 years, which gives a mixed picture of recent and longer term performance. Recent news around...
NYSE:RBLX
NYSE:RBLXEntertainment

Roblox Creator Push And AI Safety Tools Meet Depressed Share Price

Roblox has launched two new creator programs, Roblox Incubator and Roblox Jumpstart, aimed at helping developers build higher quality games for a more mature audience. The company has also rolled out AI-powered chat moderation that can automatically rephrase inappropriate messages in real time to help keep conversations safer and more civil. Roblox, listed as NYSE:RBLX, is introducing these creator programs and AI tools at a time when its share price is $62.65. The stock has seen a 16.5%...
NYSE:HRTG
NYSE:HRTGInsurance

Heritage Insurance (HRTG) Combined Ratio Breakthrough Reinforces Bullish Profitability Narrative

Heritage Insurance Holdings (HRTG) just posted its FY 2025 third quarter results, reporting revenue of US$212.5 million and basic EPS of US$1.63, alongside a combined ratio of 72.9%. This puts underwriting performance in clear focus. The company’s quarterly revenue has moved in a tight band, from US$210.3 million in Q4 2024 to US$212.5 million in Q3 2025, while basic EPS increased from US$0.66 to US$1.63 over the same period. This sets the scene for investors to examine how margins and...
TASE:NYAX
TASE:NYAXElectronic

Nayax (TASE:NYAX) Profitability Turnaround Tests High 85.3x P/E Narrative

Nayax (TASE:NYAX) posts FY 2025 results Nayax (TASE:NYAX) has put up another busy quarter, with Q3 FY 2025 revenue at US$104.3 million and basic EPS of US$0.10, alongside trailing twelve month revenue of US$369.9 million and basic EPS of US$0.65. The company has seen revenue move from US$78.1 million in Q2 FY 2024 to US$104.3 million in Q3 FY 2025, while quarterly EPS has shifted from a loss of US$0.08 per share in Q2 FY 2024 to a profit of US$0.10 per share in Q3 FY 2025. This sets up a...